Subramony SH - Search Results

1

The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications.

Selvadurai LP, Perlman SL, Wilmot GR, Subramony SH, Gomez CM, Ashizawa T, Paulson HL, Onyike CU, Rosenthal LS, Sair HI, Kuo SH, Ratai EM, Zesiewicz TA, Bushara KO, Öz G, Dietiker C, Geschwind MD, Nelson AB, Opal P, Yacoubian TA, Nopoulos PC, Shakkottai VG, Figueroa KP, Pulst SM, Morrison PE, Schmahmann JD. Selvadurai LP, et al. Among authors: subramony sh. Cerebellum. 2023 Oct;22(5):790-809. doi: 10.1007/s12311-022-01424-1. Epub 2022 Aug 12. Cerebellum. 2023. PMID: 35962273 Free PMC article.

2

Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN. Paulson HL, et al. Among authors: subramony sh. Neuron. 1997 Aug;19(2):333-44. doi: 10.1016/s0896-6273(00)80943-5. Neuron. 1997. PMID: 9292723 Free article.

3

What is Kearns-Sayre syndrome after all?

Ashizawa T, Subramony SH. Ashizawa T, et al. Among authors: subramony sh. Arch Neurol. 2001 Jul;58(7):1053-4. doi: 10.1001/archneur.58.7.1053. Arch Neurol. 2001. PMID: 11448292 No abstract available.

4

Dominantly inherited ataxias.

Gomez CM, Subramony SH. Gomez CM, et al. Among authors: subramony sh. Semin Pediatr Neurol. 2003 Sep;10(3):210-22. doi: 10.1016/s1071-9091(03)00030-5. Semin Pediatr Neurol. 2003. PMID: 14653409 Review.

5

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.

Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, Taylor P, Wilson R, Ashizawa T; Cooperative Ataxia Group. Subramony SH, et al. Neurology. 2005 Apr 12;64(7):1261-2. doi: 10.1212/01.WNL.0000156802.15466.79. Neurology. 2005. PMID: 15824358

6

Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes.

Maschke M, Oehlert G, Xie TD, Perlman S, Subramony SH, Kumar N, Ptacek LJ, Gomez CM. Maschke M, et al. Among authors: subramony sh. Mov Disord. 2005 Nov;20(11):1405-12. doi: 10.1002/mds.20533. Mov Disord. 2005. PMID: 16037936

7

Measuring Friedreich ataxia: complementary features of examination and performance measures.

Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ. Lynch DR, et al. Among authors: subramony sh. Neurology. 2006 Jun 13;66(11):1711-6. doi: 10.1212/01.wnl.0000218155.46739.90. Neurology. 2006. PMID: 16769945 Clinical Trial.

8

Antioxidant use in Friedreich ataxia.

Myers L, Farmer JM, Wilson RB, Friedman L, Tsou A, Perlman SL, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews KD, Balcer LJ, Lynch DR. Myers L, et al. Among authors: subramony sh. J Neurol Sci. 2008 Apr 15;267(1-2):174-6. doi: 10.1016/j.jns.2007.10.008. Epub 2007 Nov 7. J Neurol Sci. 2008. PMID: 17988688 Free PMC article. Clinical Trial.

9

Health related quality of life measures in Friedreich Ataxia.

Epstein E, Farmer JM, Tsou A, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews K, Wilson RB, Balcer LJ, Lynch DR. Epstein E, et al. Among authors: subramony sh. J Neurol Sci. 2008 Sep 15;272(1-2):123-8. doi: 10.1016/j.jns.2008.05.009. Epub 2008 Jun 20. J Neurol Sci. 2008. PMID: 18571673

10

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR. Friedman LS, et al. Among authors: subramony sh. Mov Disord. 2010 Mar 15;25(4):426-32. doi: 10.1002/mds.22912. Mov Disord. 2010. PMID: 20063431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page